Fang Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Fang Chen has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Xinming Liang
MGI Tech, Shenzhen, China
2 shared publications- Congcong Ma
Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
1 shared publication Dan An
MGI Tech, Shenzhen, China
1 shared publicationHuijuan Luo
BGI, Shenzhen, China
1 shared publication- Jia Kang
Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China
1 shared publication - Jie Huang
National Institutes for Food and Drug Control, Beijing, China
1 shared publication
Latest Publications
- Open Access
- 24 October 2025
- Published by Springer Nature in BMC Genomics
- Vol. 26 (1) , 1-14
Performance comparison of four exome capture platforms on DNBSEQ-Series high throughput sequencer
Whole exome sequencing (WES) technology has become a prevalent methodology in the field of human genetics research, providing an effective and affordable alternative to identify causative genetic mutations in genomic exon regions. This study focuses on the comparative assessment of four commercially available WES platforms on the DNBSEQ-Series sequencer, a platform that has not been extensively evaluated in the literature. The study provides a comprehensive comparison of data quality, capture specificity, coverage uniformity and variants detection accuracy across these platforms. The results indicate that these platforms exhibit comparable reproducibility and superior technical stability and detection accuracy on the DNBSEQ-T7 sequencer. Furthermore, the study establishes a robust workflow for probe hybridization capture that is compatible with the four commercial exome kits and the DNBSEQ-Series sequencer, offering uniform and outstanding performance, thus enhancing broader compatibility regardless of probe brand. This study contributes to filling a significant gap in the literature regarding the performance evaluation of WES platforms on the DNBSEQ-Series sequencer and provides valuable insights for researchers in human genetics research.
- 24 October 2025
- Published by Springer Nature in BMC Genomics
- Vol. 26 (1) , 1-14
Open AccessPerformance comparison of four exome capture platforms on DNBSEQ-Series high throughput sequencer
Whole exome sequencing (WES) technology has become a prevalent methodology in the field of human genetics research, providing an effective and affordable alternative to identify causative genetic mutations in genomic exon regions. This study focuses on the comparative assessment of four commercially available WES platforms on the DNBSEQ-Series sequencer, a platform that has not been extensively evaluated in the literature. The study provides a comprehensive comparison of data quality, capture specificity, coverage uniformity and variants detection accuracy across these platforms. The results indicate that these platforms exhibit comparable reproducibility and superior technical stability and detection accuracy on the DNBSEQ-T7 sequencer. Furthermore, the study establishes a robust workflow for probe hybridization capture that is compatible with the four commercial exome kits and the DNBSEQ-Series sequencer, offering uniform and outstanding performance, thus enhancing broader compatibility regardless of probe brand. This study contributes to filling a significant gap in the literature regarding the performance evaluation of WES platforms on the DNBSEQ-Series sequencer and provides valuable insights for researchers in human genetics research.
- Open Access
- 25 March 2025
- Published by Springer Nature in BMC Genomics
- Vol. 26 (1) , 1-14
Performance evaluation of structural variation detection using DNBSEQ whole-genome sequencing
DNBSEQ platforms have been widely used for variation detection, including single-nucleotide variants (SNVs) and short insertions and deletions (INDELs), which is comparable to Illumina. However, the performance and even characteristics of structural variations (SVs) detection using DNBSEQ platforms are still unclear. In this study, we assessed the detection of SVs using 40 tools on eight DNBSEQ whole-genome sequencing (WGS) datasets and two Illumina WGS datasets of NA12878. Our findings confirmed that the performance of SVs detection using the same tool on DNBSEQ and Illumina datasets was highly consistent, with correlations greater than 0.80 on metrics of number, size, precision and sensitivity, respectively. Furthermore, we constructed a “DNBSEQ” SV set (4,785 SVs) from the DNBSEQ datasets and an “Illumina” SV set (6,797 SVs) from the Illumina datasets. We found that these two SV sets were highly consistent of SV sites and genomic characteristics, including repetitive regions, GC distribution, difficult-to-sequence regions, and gene features, indicating the robustness of our comparative analysis and highlights the value of both platforms in understanding the genomic context of SVs. Our study systematically analyzed and characterized germline SVs detected on WGS datasets sequenced from DNBSEQ platforms, providing a benchmark resource for further studies of SVs using DNBSEQ platforms.
- 25 March 2025
- Published by Springer Nature in BMC Genomics
- Vol. 26 (1) , 1-14
Open AccessPerformance evaluation of structural variation detection using DNBSEQ whole-genome sequencing
DNBSEQ platforms have been widely used for variation detection, including single-nucleotide variants (SNVs) and short insertions and deletions (INDELs), which is comparable to Illumina. However, the performance and even characteristics of structural variations (SVs) detection using DNBSEQ platforms are still unclear. In this study, we assessed the detection of SVs using 40 tools on eight DNBSEQ whole-genome sequencing (WGS) datasets and two Illumina WGS datasets of NA12878. Our findings confirmed that the performance of SVs detection using the same tool on DNBSEQ and Illumina datasets was highly consistent, with correlations greater than 0.80 on metrics of number, size, precision and sensitivity, respectively. Furthermore, we constructed a “DNBSEQ” SV set (4,785 SVs) from the DNBSEQ datasets and an “Illumina” SV set (6,797 SVs) from the Illumina datasets. We found that these two SV sets were highly consistent of SV sites and genomic characteristics, including repetitive regions, GC distribution, difficult-to-sequence regions, and gene features, indicating the robustness of our comparative analysis and highlights the value of both platforms in understanding the genomic context of SVs. Our study systematically analyzed and characterized germline SVs detected on WGS datasets sequenced from DNBSEQ platforms, providing a benchmark resource for further studies of SVs using DNBSEQ platforms.
- Open Access
- 25 October 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (21) , 12853
Clinical and Genetic Characteristics of a Cohort with Distal Vaginal Atresia
Distal vaginal atresia is a rare abnormality of female reproductive tract in which the vagina is closed or absent. The distal vagina may be replaced by fibrous tissue and the condition is often not diagnosed until a girl fails to begin having periods at puberty. Although it is a congenital disorder, potential genetic causes of distal vaginal atresia are still unknown. We recruited a cohort of 39 patients with distal vaginal atresia and analyzed their phenotypic and genetic features. In addition to the complaint of distal vaginal atresia, approximately 17.9% (7/39) of the patients had other Müllerian anomalies, and 17.9% (7/39) of the patients had other structural abnormalities, including renal-tract, skeletal and cardiac anomalies. Using genome sequencing, we identified two fragment duplications on 17q12 encompassing HNF1B and LHX1, two dosage-sensitive genes with candidate pathogenic variants, in two unrelated patients. A large fragment of uniparental disomy was detected in another patient, affecting genes involved in cell morphogenesis and connective tissue development. Additionally, we reported two variants on TBX3 and AXL, leading to distal vaginal atresia in mutated mouse model, in our clinical subjects for the first time. Essential biological functions of these detected genes with pathogenic variants included regulating reproductive development and cell fate and patterning during embryogenesis. We displayed the comprehensive clinical and genetic characteristic of a cohort with distal vaginal atresia and they were highly heterogeneous both phenotypically and genetically. The duplication of 17q12 in our cohort could help to expand its phenotypic spectrum and potential contribution to the distal vaginal atresia. Our findings of pathogenic genetic variants and associated phenotypes in our cohort could provide evidence and new insight for further research attempting to reveal genetic causes of distal vaginal atresia.
- 25 October 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (21) , 12853
Open AccessClinical and Genetic Characteristics of a Cohort with Distal Vaginal Atresia
Distal vaginal atresia is a rare abnormality of female reproductive tract in which the vagina is closed or absent. The distal vagina may be replaced by fibrous tissue and the condition is often not diagnosed until a girl fails to begin having periods at puberty. Although it is a congenital disorder, potential genetic causes of distal vaginal atresia are still unknown. We recruited a cohort of 39 patients with distal vaginal atresia and analyzed their phenotypic and genetic features. In addition to the complaint of distal vaginal atresia, approximately 17.9% (7/39) of the patients had other Müllerian anomalies, and 17.9% (7/39) of the patients had other structural abnormalities, including renal-tract, skeletal and cardiac anomalies. Using genome sequencing, we identified two fragment duplications on 17q12 encompassing HNF1B and LHX1, two dosage-sensitive genes with candidate pathogenic variants, in two unrelated patients. A large fragment of uniparental disomy was detected in another patient, affecting genes involved in cell morphogenesis and connective tissue development. Additionally, we reported two variants on TBX3 and AXL, leading to distal vaginal atresia in mutated mouse model, in our clinical subjects for the first time. Essential biological functions of these detected genes with pathogenic variants included regulating reproductive development and cell fate and patterning during embryogenesis. We displayed the comprehensive clinical and genetic characteristic of a cohort with distal vaginal atresia and they were highly heterogeneous both phenotypically and genetically. The duplication of 17q12 in our cohort could help to expand its phenotypic spectrum and potential contribution to the distal vaginal atresia. Our findings of pathogenic genetic variants and associated phenotypes in our cohort could provide evidence and new insight for further research attempting to reveal genetic causes of distal vaginal atresia.